S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion
Standard
S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion. / Werfel, Thomas; Heratizadeh, Annice; Aberer, Werner; Ahrens, Frank; Augustin, Matthias; Biedermann, Tilo; Diepgen, Thomas; Fölster-Holst, Regina; Gieler, Uwe; Kahle, Julia; Kapp, Alexander; Nast, Alexander; Nemat, Katja; Ott, Hagen; Przybilla, Bernhard; Roecken, Martin; Schlaeger, Martin; Schmid-Grendelmeier, Peter; Schmitt, Jochen; Schwennesen, Thomas; Staab, Doris; Worm, Margitta.
In: J DTSCH DERMATOL GES, Vol. 14, No. 1, 01.2016, p. 92-105.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion
AU - Werfel, Thomas
AU - Heratizadeh, Annice
AU - Aberer, Werner
AU - Ahrens, Frank
AU - Augustin, Matthias
AU - Biedermann, Tilo
AU - Diepgen, Thomas
AU - Fölster-Holst, Regina
AU - Gieler, Uwe
AU - Kahle, Julia
AU - Kapp, Alexander
AU - Nast, Alexander
AU - Nemat, Katja
AU - Ott, Hagen
AU - Przybilla, Bernhard
AU - Roecken, Martin
AU - Schlaeger, Martin
AU - Schmid-Grendelmeier, Peter
AU - Schmitt, Jochen
AU - Schwennesen, Thomas
AU - Staab, Doris
AU - Worm, Margitta
N1 - © 2015 The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.
PY - 2016/1
Y1 - 2016/1
N2 - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).
AB - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).
KW - Anti-Inflammatory Agents
KW - Dermatitis, Atopic
KW - Dermatology
KW - Evidence-Based Medicine
KW - Germany
KW - Humans
KW - Practice Guidelines as Topic
KW - Skin Tests
KW - Treatment Outcome
KW - Journal Article
U2 - 10.1111/ddg.12871
DO - 10.1111/ddg.12871
M3 - SCORING: Zeitschriftenaufsatz
C2 - 26713654
VL - 14
SP - 92
EP - 105
JO - J DTSCH DERMATOL GES
JF - J DTSCH DERMATOL GES
SN - 1610-0379
IS - 1
ER -